nodes	percent_of_prediction	percent_of_DWPC	metapath
Zanamivir—NEU2—Glycosphingolipid metabolism—SMPD3—hematologic cancer	0.0226	0.101	CbGpPWpGaD
Zanamivir—NEU2—Glycosphingolipid metabolism—GBA—hematologic cancer	0.016	0.0714	CbGpPWpGaD
Zanamivir—NEU2—Synthesis of substrates in N-glycan biosythesis—DPM1—hematologic cancer	0.0157	0.0704	CbGpPWpGaD
Zanamivir—NEU2—Sphingolipid metabolism—SMPD3—hematologic cancer	0.014	0.0628	CbGpPWpGaD
Zanamivir—NEU2—Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein—DPM1—hematologic cancer	0.0128	0.0575	CbGpPWpGaD
Zanamivir—NEU2—Sphingolipid metabolism—GBA—hematologic cancer	0.00988	0.0442	CbGpPWpGaD
Zanamivir—NEU2—Asparagine N-linked glycosylation—DPM1—hematologic cancer	0.00816	0.0365	CbGpPWpGaD
Zanamivir—NEU2—Asparagine N-linked glycosylation—PREB—hematologic cancer	0.00738	0.033	CbGpPWpGaD
Zanamivir—NEU2—Sphingolipid metabolism—SPHK1—hematologic cancer	0.00623	0.0279	CbGpPWpGaD
Zanamivir—NEU2—Post-translational protein modification—GCNT4—hematologic cancer	0.00528	0.0236	CbGpPWpGaD
Zanamivir—NEU2—Post-translational protein modification—DPM1—hematologic cancer	0.00422	0.0189	CbGpPWpGaD
Zanamivir—NEU2—Post-translational protein modification—PREB—hematologic cancer	0.00382	0.0171	CbGpPWpGaD
Zanamivir—NEU2—Post-translational protein modification—GCNT1—hematologic cancer	0.00366	0.0164	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—LDHD—hematologic cancer	0.00331	0.0148	CbGpPWpGaD
Zanamivir—NEU2—Post-translational protein modification—MUC1—hematologic cancer	0.00311	0.0139	CbGpPWpGaD
Zanamivir—NEU2—Asparagine N-linked glycosylation—CALR—hematologic cancer	0.00291	0.013	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—PHYH—hematologic cancer	0.0029	0.013	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—SMPD3—hematologic cancer	0.00265	0.0119	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—GCNT4—hematologic cancer	0.00251	0.0112	CbGpPWpGaD
Zanamivir—NEU2—Post-translational protein modification—SUMO1—hematologic cancer	0.00219	0.00982	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—CTSZ—hematologic cancer	0.00213	0.00954	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—ANPEP—hematologic cancer	0.00213	0.00954	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—DPM1—hematologic cancer	0.002	0.00897	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—ASNS—hematologic cancer	0.002	0.00897	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—GBA—hematologic cancer	0.00187	0.00837	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—PREB—hematologic cancer	0.00181	0.00811	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—GCNT1—hematologic cancer	0.00174	0.00778	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—FHL2—hematologic cancer	0.00152	0.00682	CbGpPWpGaD
Zanamivir—NEU2—Post-translational protein modification—CALR—hematologic cancer	0.00151	0.00675	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—MUC1—hematologic cancer	0.00148	0.00661	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—ARNTL—hematologic cancer	0.00133	0.00596	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—FTCD—hematologic cancer	0.00129	0.00578	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—PHYH—hematologic cancer	0.00129	0.00578	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—GMPS—hematologic cancer	0.00129	0.00578	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—RPLP1—hematologic cancer	0.00129	0.00578	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	0.00128	0.00572	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	0.00122	0.00545	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	0.0012	0.00539	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—TUBB2A—hematologic cancer	0.00119	0.00531	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—SMPD3—hematologic cancer	0.00118	0.00529	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	0.00118	0.00528	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	0.0011	0.00493	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	0.00107	0.00481	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—MME—hematologic cancer	0.00105	0.00471	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—CMA1—hematologic cancer	0.00104	0.00466	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—SUMO1—hematologic cancer	0.00104	0.00466	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—DCK—hematologic cancer	0.00103	0.00462	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—B3GAT1—hematologic cancer	0.00103	0.00462	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—ASNS—hematologic cancer	0.00103	0.00462	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—SPHK1—hematologic cancer	0.00102	0.00456	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	0.00101	0.00452	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—HDC—hematologic cancer	0.000979	0.00438	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	0.000913	0.00409	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—RPS14—hematologic cancer	0.000913	0.00409	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—CDA—hematologic cancer	0.000896	0.00401	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—PC—hematologic cancer	0.000862	0.00386	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—SLC35B2—hematologic cancer	0.000833	0.00373	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—GBA—hematologic cancer	0.000833	0.00373	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—EIF4EBP1—hematologic cancer	0.000798	0.00357	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—MTAP—hematologic cancer	0.000761	0.00341	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—HSPA5—hematologic cancer	0.000738	0.0033	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—CALR—hematologic cancer	0.000715	0.0032	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—FBXW7—hematologic cancer	0.000692	0.0031	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—FHL2—hematologic cancer	0.000679	0.00304	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—AGRN—hematologic cancer	0.000666	0.00298	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—IDH2—hematologic cancer	0.000631	0.00282	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—HMMR—hematologic cancer	0.000631	0.00282	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	0.000595	0.00266	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—ARNTL—hematologic cancer	0.000593	0.00266	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—ACP5—hematologic cancer	0.000577	0.00258	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—CA9—hematologic cancer	0.000577	0.00258	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—NCOR2—hematologic cancer	0.00057	0.00255	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—IDH1—hematologic cancer	0.000543	0.00243	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—ABCC3—hematologic cancer	0.000537	0.0024	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—TXN—hematologic cancer	0.000537	0.0024	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—GSTO1—hematologic cancer	0.000537	0.0024	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—SPHK1—hematologic cancer	0.000525	0.00235	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—UGT1A1—hematologic cancer	0.000504	0.00226	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—SLC22A1—hematologic cancer	0.000491	0.0022	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—CRABP1—hematologic cancer	0.000491	0.0022	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—ALOX5—hematologic cancer	0.000478	0.00214	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—NUP98—hematologic cancer	0.000463	0.00207	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—NCOA3—hematologic cancer	0.00045	0.00201	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—ADCY7—hematologic cancer	0.00045	0.00201	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—NUP214—hematologic cancer	0.000446	0.002	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	0.000442	0.00198	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—ABCG2—hematologic cancer	0.000437	0.00196	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—MTR—hematologic cancer	0.000437	0.00196	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—ENO2—hematologic cancer	0.000429	0.00192	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—GSTT1—hematologic cancer	0.000416	0.00186	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	0.00041	0.00183	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—SDC1—hematologic cancer	0.000407	0.00182	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	0.000388	0.00174	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	0.000383	0.00172	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	0.000367	0.00164	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—CCL2—hematologic cancer	0.000356	0.00159	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—NQO1—hematologic cancer	0.000346	0.00155	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—CD44—hematologic cancer	0.000346	0.00155	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	0.000339	0.00152	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—CYCS—hematologic cancer	0.000327	0.00146	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—HSP90AA1—hematologic cancer	0.000325	0.00145	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	0.000293	0.00131	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—GSTP1—hematologic cancer	0.000288	0.00129	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	0.000279	0.00125	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—ABCB1—hematologic cancer	0.000273	0.00122	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—GSTM1—hematologic cancer	0.000265	0.00119	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—NCOR1—hematologic cancer	0.000265	0.00119	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—MTHFR—hematologic cancer	0.000234	0.00105	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	0.000206	0.000924	CbGpPWpGaD
Zanamivir—Rash—Ifosfamide—hematologic cancer	0.0002	0.000257	CcSEcCtD
Zanamivir—Dermatitis—Ifosfamide—hematologic cancer	0.000199	0.000257	CcSEcCtD
Zanamivir—Erythema multiforme—Methotrexate—hematologic cancer	0.000199	0.000257	CcSEcCtD
Zanamivir—Dizziness—Irinotecan—hematologic cancer	0.000199	0.000256	CcSEcCtD
Zanamivir—Urticaria—Etoposide—hematologic cancer	0.000199	0.000256	CcSEcCtD
Zanamivir—Haemoglobin—Epirubicin—hematologic cancer	0.000198	0.000255	CcSEcCtD
Zanamivir—Malaise—Prednisone—hematologic cancer	0.000198	0.000255	CcSEcCtD
Zanamivir—Body temperature increased—Etoposide—hematologic cancer	0.000198	0.000254	CcSEcCtD
Zanamivir—Abdominal pain—Etoposide—hematologic cancer	0.000198	0.000254	CcSEcCtD
Zanamivir—Haemorrhage—Epirubicin—hematologic cancer	0.000197	0.000254	CcSEcCtD
Zanamivir—Syncope—Prednisone—hematologic cancer	0.000197	0.000254	CcSEcCtD
Zanamivir—NEU2—Metabolism—PIK3CG—hematologic cancer	0.000197	0.000881	CbGpPWpGaD
Zanamivir—Vomiting—Vincristine—hematologic cancer	0.000196	0.000253	CcSEcCtD
Zanamivir—Anorexia—Dexamethasone—hematologic cancer	0.000196	0.000253	CcSEcCtD
Zanamivir—Anorexia—Betamethasone—hematologic cancer	0.000196	0.000253	CcSEcCtD
Zanamivir—Urticaria—Prednisolone—hematologic cancer	0.000196	0.000252	CcSEcCtD
Zanamivir—Asthenia—Cisplatin—hematologic cancer	0.000196	0.000252	CcSEcCtD
Zanamivir—Fatigue—Triamcinolone—hematologic cancer	0.000195	0.000252	CcSEcCtD
Zanamivir—Rash—Vincristine—hematologic cancer	0.000195	0.000251	CcSEcCtD
Zanamivir—Dermatitis—Vincristine—hematologic cancer	0.000194	0.00025	CcSEcCtD
Zanamivir—Pain—Triamcinolone—hematologic cancer	0.000194	0.00025	CcSEcCtD
Zanamivir—Headache—Vincristine—hematologic cancer	0.000193	0.000249	CcSEcCtD
Zanamivir—Loss of consciousness—Prednisone—hematologic cancer	0.000193	0.000248	CcSEcCtD
Zanamivir—Nausea—Carmustine—hematologic cancer	0.000192	0.000247	CcSEcCtD
Zanamivir—Vomiting—Mitoxantrone—hematologic cancer	0.000191	0.000246	CcSEcCtD
Zanamivir—Vomiting—Irinotecan—hematologic cancer	0.000191	0.000246	CcSEcCtD
Zanamivir—Sinusitis—Doxorubicin—hematologic cancer	0.000191	0.000246	CcSEcCtD
Zanamivir—Nausea—Alitretinoin—hematologic cancer	0.00019	0.000245	CcSEcCtD
Zanamivir—Convulsion—Prednisone—hematologic cancer	0.00019	0.000245	CcSEcCtD
Zanamivir—Rash—Mitoxantrone—hematologic cancer	0.000189	0.000244	CcSEcCtD
Zanamivir—Rash—Irinotecan—hematologic cancer	0.000189	0.000244	CcSEcCtD
Zanamivir—Dermatitis—Irinotecan—hematologic cancer	0.000189	0.000244	CcSEcCtD
Zanamivir—Dermatitis—Mitoxantrone—hematologic cancer	0.000189	0.000244	CcSEcCtD
Zanamivir—Chills—Methotrexate—hematologic cancer	0.000189	0.000244	CcSEcCtD
Zanamivir—Headache—Mitoxantrone—hematologic cancer	0.000188	0.000242	CcSEcCtD
Zanamivir—Headache—Irinotecan—hematologic cancer	0.000188	0.000242	CcSEcCtD
Zanamivir—Nausea—Ifosfamide—hematologic cancer	0.000188	0.000242	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Betamethasone—hematologic cancer	0.000187	0.000241	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	0.000187	0.000241	CcSEcCtD
Zanamivir—Myalgia—Prednisone—hematologic cancer	0.000187	0.000241	CcSEcCtD
Zanamivir—Arthralgia—Prednisone—hematologic cancer	0.000187	0.000241	CcSEcCtD
Zanamivir—Feeling abnormal—Triamcinolone—hematologic cancer	0.000187	0.000241	CcSEcCtD
Zanamivir—Diarrhoea—Cisplatin—hematologic cancer	0.000187	0.00024	CcSEcCtD
Zanamivir—Erythema multiforme—Epirubicin—hematologic cancer	0.000186	0.00024	CcSEcCtD
Zanamivir—Anxiety—Prednisone—hematologic cancer	0.000186	0.00024	CcSEcCtD
Zanamivir—Vomiting—Gemcitabine—hematologic cancer	0.000186	0.00024	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	0.000186	0.000239	CcSEcCtD
Zanamivir—Discomfort—Prednisone—hematologic cancer	0.000185	0.000238	CcSEcCtD
Zanamivir—Rash—Gemcitabine—hematologic cancer	0.000185	0.000238	CcSEcCtD
Zanamivir—Dermatitis—Gemcitabine—hematologic cancer	0.000184	0.000237	CcSEcCtD
Zanamivir—Hypersensitivity—Etoposide—hematologic cancer	0.000184	0.000237	CcSEcCtD
Zanamivir—Haemoglobin—Doxorubicin—hematologic cancer	0.000183	0.000236	CcSEcCtD
Zanamivir—Headache—Gemcitabine—hematologic cancer	0.000183	0.000236	CcSEcCtD
Zanamivir—Nausea—Vincristine—hematologic cancer	0.000183	0.000236	CcSEcCtD
Zanamivir—Haemorrhage—Doxorubicin—hematologic cancer	0.000183	0.000235	CcSEcCtD
Zanamivir—NEU2—Metabolism—CREBBP—hematologic cancer	0.000182	0.000816	CbGpPWpGaD
Zanamivir—Hypersensitivity—Prednisolone—hematologic cancer	0.000182	0.000234	CcSEcCtD
Zanamivir—Urticaria—Triamcinolone—hematologic cancer	0.00018	0.000232	CcSEcCtD
Zanamivir—Asthenia—Etoposide—hematologic cancer	0.000179	0.000231	CcSEcCtD
Zanamivir—Body temperature increased—Triamcinolone—hematologic cancer	0.000179	0.000231	CcSEcCtD
Zanamivir—Anaphylactic shock—Prednisone—hematologic cancer	0.000179	0.000231	CcSEcCtD
Zanamivir—Decreased appetite—Betamethasone—hematologic cancer	0.000179	0.00023	CcSEcCtD
Zanamivir—Decreased appetite—Dexamethasone—hematologic cancer	0.000179	0.00023	CcSEcCtD
Zanamivir—Nausea—Irinotecan—hematologic cancer	0.000179	0.00023	CcSEcCtD
Zanamivir—Nausea—Mitoxantrone—hematologic cancer	0.000179	0.00023	CcSEcCtD
Zanamivir—Infection—Prednisone—hematologic cancer	0.000178	0.000229	CcSEcCtD
Zanamivir—Fatigue—Dexamethasone—hematologic cancer	0.000177	0.000228	CcSEcCtD
Zanamivir—Fatigue—Betamethasone—hematologic cancer	0.000177	0.000228	CcSEcCtD
Zanamivir—Chills—Epirubicin—hematologic cancer	0.000177	0.000228	CcSEcCtD
Zanamivir—Shock—Prednisone—hematologic cancer	0.000176	0.000227	CcSEcCtD
Zanamivir—Arrhythmia—Epirubicin—hematologic cancer	0.000176	0.000227	CcSEcCtD
Zanamivir—Pain—Betamethasone—hematologic cancer	0.000176	0.000227	CcSEcCtD
Zanamivir—Pain—Dexamethasone—hematologic cancer	0.000176	0.000227	CcSEcCtD
Zanamivir—Skin disorder—Prednisone—hematologic cancer	0.000174	0.000224	CcSEcCtD
Zanamivir—Nausea—Gemcitabine—hematologic cancer	0.000174	0.000224	CcSEcCtD
Zanamivir—Vomiting—Cisplatin—hematologic cancer	0.000173	0.000223	CcSEcCtD
Zanamivir—NEU2—Metabolism—PIK3CD—hematologic cancer	0.000173	0.000774	CbGpPWpGaD
Zanamivir—Erythema multiforme—Doxorubicin—hematologic cancer	0.000173	0.000222	CcSEcCtD
Zanamivir—Rash—Cisplatin—hematologic cancer	0.000172	0.000222	CcSEcCtD
Zanamivir—Dermatitis—Cisplatin—hematologic cancer	0.000172	0.000221	CcSEcCtD
Zanamivir—Diarrhoea—Etoposide—hematologic cancer	0.000171	0.00022	CcSEcCtD
Zanamivir—Anorexia—Prednisone—hematologic cancer	0.000171	0.00022	CcSEcCtD
Zanamivir—NEU2—Metabolism—ALB—hematologic cancer	0.000171	0.000764	CbGpPWpGaD
Zanamivir—Ill-defined disorder—Methotrexate—hematologic cancer	0.00017	0.000219	CcSEcCtD
Zanamivir—Feeling abnormal—Betamethasone—hematologic cancer	0.00017	0.000218	CcSEcCtD
Zanamivir—Feeling abnormal—Dexamethasone—hematologic cancer	0.00017	0.000218	CcSEcCtD
Zanamivir—Gastrointestinal pain—Dexamethasone—hematologic cancer	0.000168	0.000217	CcSEcCtD
Zanamivir—Gastrointestinal pain—Betamethasone—hematologic cancer	0.000168	0.000217	CcSEcCtD
Zanamivir—Hypersensitivity—Triamcinolone—hematologic cancer	0.000167	0.000215	CcSEcCtD
Zanamivir—Malaise—Methotrexate—hematologic cancer	0.000165	0.000213	CcSEcCtD
Zanamivir—Dizziness—Etoposide—hematologic cancer	0.000165	0.000213	CcSEcCtD
Zanamivir—Chills—Doxorubicin—hematologic cancer	0.000164	0.000211	CcSEcCtD
Zanamivir—Urticaria—Dexamethasone—hematologic cancer	0.000163	0.00021	CcSEcCtD
Zanamivir—Urticaria—Betamethasone—hematologic cancer	0.000163	0.00021	CcSEcCtD
Zanamivir—NEU2—Metabolism—PIK3R1—hematologic cancer	0.000163	0.000731	CbGpPWpGaD
Zanamivir—Musculoskeletal discomfort—Prednisone—hematologic cancer	0.000163	0.00021	CcSEcCtD
Zanamivir—Dizziness—Prednisolone—hematologic cancer	0.000163	0.00021	CcSEcCtD
Zanamivir—Arrhythmia—Doxorubicin—hematologic cancer	0.000163	0.00021	CcSEcCtD
Zanamivir—Asthenia—Triamcinolone—hematologic cancer	0.000163	0.000209	CcSEcCtD
Zanamivir—Abdominal pain—Dexamethasone—hematologic cancer	0.000163	0.000209	CcSEcCtD
Zanamivir—Body temperature increased—Betamethasone—hematologic cancer	0.000163	0.000209	CcSEcCtD
Zanamivir—Body temperature increased—Dexamethasone—hematologic cancer	0.000163	0.000209	CcSEcCtD
Zanamivir—Abdominal pain—Betamethasone—hematologic cancer	0.000163	0.000209	CcSEcCtD
Zanamivir—Nausea—Cisplatin—hematologic cancer	0.000162	0.000209	CcSEcCtD
Zanamivir—Cough—Methotrexate—hematologic cancer	0.00016	0.000206	CcSEcCtD
Zanamivir—Ill-defined disorder—Epirubicin—hematologic cancer	0.000159	0.000205	CcSEcCtD
Zanamivir—Convulsion—Methotrexate—hematologic cancer	0.000159	0.000205	CcSEcCtD
Zanamivir—Vomiting—Etoposide—hematologic cancer	0.000159	0.000205	CcSEcCtD
Zanamivir—Agitation—Epirubicin—hematologic cancer	0.000158	0.000203	CcSEcCtD
Zanamivir—Rash—Etoposide—hematologic cancer	0.000158	0.000203	CcSEcCtD
Zanamivir—Dermatitis—Etoposide—hematologic cancer	0.000157	0.000203	CcSEcCtD
Zanamivir—Headache—Etoposide—hematologic cancer	0.000157	0.000202	CcSEcCtD
Zanamivir—Myalgia—Methotrexate—hematologic cancer	0.000156	0.000201	CcSEcCtD
Zanamivir—Arthralgia—Methotrexate—hematologic cancer	0.000156	0.000201	CcSEcCtD
Zanamivir—Decreased appetite—Prednisone—hematologic cancer	0.000156	0.000201	CcSEcCtD
Zanamivir—Rash—Prednisolone—hematologic cancer	0.000155	0.0002	CcSEcCtD
Zanamivir—Dermatitis—Prednisolone—hematologic cancer	0.000155	0.0002	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	0.000155	0.0002	CcSEcCtD
Zanamivir—Malaise—Epirubicin—hematologic cancer	0.000155	0.000199	CcSEcCtD
Zanamivir—Fatigue—Prednisone—hematologic cancer	0.000154	0.000199	CcSEcCtD
Zanamivir—Headache—Prednisolone—hematologic cancer	0.000154	0.000199	CcSEcCtD
Zanamivir—Discomfort—Methotrexate—hematologic cancer	0.000154	0.000199	CcSEcCtD
Zanamivir—Syncope—Epirubicin—hematologic cancer	0.000154	0.000198	CcSEcCtD
Zanamivir—Confusional state—Methotrexate—hematologic cancer	0.000151	0.000194	CcSEcCtD
Zanamivir—Loss of consciousness—Epirubicin—hematologic cancer	0.000151	0.000194	CcSEcCtD
Zanamivir—NEU2—Metabolism—PIK3CB—hematologic cancer	0.000151	0.000675	CbGpPWpGaD
Zanamivir—Dizziness—Triamcinolone—hematologic cancer	0.00015	0.000193	CcSEcCtD
Zanamivir—Cough—Epirubicin—hematologic cancer	0.00015	0.000193	CcSEcCtD
Zanamivir—Anaphylactic shock—Methotrexate—hematologic cancer	0.00015	0.000193	CcSEcCtD
Zanamivir—Convulsion—Epirubicin—hematologic cancer	0.000149	0.000192	CcSEcCtD
Zanamivir—Infection—Methotrexate—hematologic cancer	0.000149	0.000192	CcSEcCtD
Zanamivir—Nausea—Etoposide—hematologic cancer	0.000148	0.000191	CcSEcCtD
Zanamivir—Feeling abnormal—Prednisone—hematologic cancer	0.000148	0.00019	CcSEcCtD
Zanamivir—Asthenia—Dexamethasone—hematologic cancer	0.000148	0.00019	CcSEcCtD
Zanamivir—Asthenia—Betamethasone—hematologic cancer	0.000148	0.00019	CcSEcCtD
Zanamivir—Ill-defined disorder—Doxorubicin—hematologic cancer	0.000147	0.00019	CcSEcCtD
Zanamivir—Gastrointestinal pain—Prednisone—hematologic cancer	0.000147	0.000189	CcSEcCtD
Zanamivir—Nausea—Prednisolone—hematologic cancer	0.000146	0.000189	CcSEcCtD
Zanamivir—Arthralgia—Epirubicin—hematologic cancer	0.000146	0.000188	CcSEcCtD
Zanamivir—Myalgia—Epirubicin—hematologic cancer	0.000146	0.000188	CcSEcCtD
Zanamivir—Agitation—Doxorubicin—hematologic cancer	0.000146	0.000188	CcSEcCtD
Zanamivir—Anxiety—Epirubicin—hematologic cancer	0.000146	0.000188	CcSEcCtD
Zanamivir—Skin disorder—Methotrexate—hematologic cancer	0.000145	0.000187	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	0.000145	0.000187	CcSEcCtD
Zanamivir—Discomfort—Epirubicin—hematologic cancer	0.000144	0.000186	CcSEcCtD
Zanamivir—Vomiting—Triamcinolone—hematologic cancer	0.000144	0.000186	CcSEcCtD
Zanamivir—Malaise—Doxorubicin—hematologic cancer	0.000143	0.000184	CcSEcCtD
Zanamivir—Rash—Triamcinolone—hematologic cancer	0.000143	0.000184	CcSEcCtD
Zanamivir—Dermatitis—Triamcinolone—hematologic cancer	0.000143	0.000184	CcSEcCtD
Zanamivir—Anorexia—Methotrexate—hematologic cancer	0.000143	0.000184	CcSEcCtD
Zanamivir—Syncope—Doxorubicin—hematologic cancer	0.000142	0.000183	CcSEcCtD
Zanamivir—Urticaria—Prednisone—hematologic cancer	0.000142	0.000183	CcSEcCtD
Zanamivir—Headache—Triamcinolone—hematologic cancer	0.000142	0.000183	CcSEcCtD
Zanamivir—Abdominal pain—Prednisone—hematologic cancer	0.000142	0.000182	CcSEcCtD
Zanamivir—Body temperature increased—Prednisone—hematologic cancer	0.000142	0.000182	CcSEcCtD
Zanamivir—Confusional state—Epirubicin—hematologic cancer	0.000141	0.000182	CcSEcCtD
Zanamivir—Diarrhoea—Betamethasone—hematologic cancer	0.000141	0.000181	CcSEcCtD
Zanamivir—Diarrhoea—Dexamethasone—hematologic cancer	0.000141	0.000181	CcSEcCtD
Zanamivir—Anaphylactic shock—Epirubicin—hematologic cancer	0.00014	0.00018	CcSEcCtD
Zanamivir—Loss of consciousness—Doxorubicin—hematologic cancer	0.00014	0.00018	CcSEcCtD
Zanamivir—Infection—Epirubicin—hematologic cancer	0.000139	0.000179	CcSEcCtD
Zanamivir—Cough—Doxorubicin—hematologic cancer	0.000139	0.000179	CcSEcCtD
Zanamivir—Shock—Epirubicin—hematologic cancer	0.000138	0.000178	CcSEcCtD
Zanamivir—Convulsion—Doxorubicin—hematologic cancer	0.000138	0.000177	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Methotrexate—hematologic cancer	0.000136	0.000176	CcSEcCtD
Zanamivir—Skin disorder—Epirubicin—hematologic cancer	0.000136	0.000175	CcSEcCtD
Zanamivir—Dizziness—Betamethasone—hematologic cancer	0.000136	0.000175	CcSEcCtD
Zanamivir—Dizziness—Dexamethasone—hematologic cancer	0.000136	0.000175	CcSEcCtD
Zanamivir—Myalgia—Doxorubicin—hematologic cancer	0.000135	0.000174	CcSEcCtD
Zanamivir—Arthralgia—Doxorubicin—hematologic cancer	0.000135	0.000174	CcSEcCtD
Zanamivir—Anxiety—Doxorubicin—hematologic cancer	0.000135	0.000174	CcSEcCtD
Zanamivir—Nausea—Triamcinolone—hematologic cancer	0.000135	0.000173	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	0.000134	0.000173	CcSEcCtD
Zanamivir—Discomfort—Doxorubicin—hematologic cancer	0.000134	0.000172	CcSEcCtD
Zanamivir—Anorexia—Epirubicin—hematologic cancer	0.000134	0.000172	CcSEcCtD
Zanamivir—Dyspnoea—Methotrexate—hematologic cancer	0.000133	0.000172	CcSEcCtD
Zanamivir—Hypersensitivity—Prednisone—hematologic cancer	0.000132	0.00017	CcSEcCtD
Zanamivir—Vomiting—Betamethasone—hematologic cancer	0.000131	0.000168	CcSEcCtD
Zanamivir—Vomiting—Dexamethasone—hematologic cancer	0.000131	0.000168	CcSEcCtD
Zanamivir—Confusional state—Doxorubicin—hematologic cancer	0.000131	0.000168	CcSEcCtD
Zanamivir—NEU2—Metabolism—PTEN—hematologic cancer	0.00013	0.000583	CbGpPWpGaD
Zanamivir—Decreased appetite—Methotrexate—hematologic cancer	0.00013	0.000168	CcSEcCtD
Zanamivir—Rash—Dexamethasone—hematologic cancer	0.00013	0.000167	CcSEcCtD
Zanamivir—Rash—Betamethasone—hematologic cancer	0.00013	0.000167	CcSEcCtD
Zanamivir—Anaphylactic shock—Doxorubicin—hematologic cancer	0.00013	0.000167	CcSEcCtD
Zanamivir—Dermatitis—Dexamethasone—hematologic cancer	0.00013	0.000167	CcSEcCtD
Zanamivir—Dermatitis—Betamethasone—hematologic cancer	0.00013	0.000167	CcSEcCtD
Zanamivir—Fatigue—Methotrexate—hematologic cancer	0.000129	0.000166	CcSEcCtD
Zanamivir—Headache—Dexamethasone—hematologic cancer	0.000129	0.000166	CcSEcCtD
Zanamivir—Headache—Betamethasone—hematologic cancer	0.000129	0.000166	CcSEcCtD
Zanamivir—Infection—Doxorubicin—hematologic cancer	0.000129	0.000166	CcSEcCtD
Zanamivir—Asthenia—Prednisone—hematologic cancer	0.000129	0.000166	CcSEcCtD
Zanamivir—Pain—Methotrexate—hematologic cancer	0.000128	0.000165	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Epirubicin—hematologic cancer	0.000128	0.000164	CcSEcCtD
Zanamivir—Shock—Doxorubicin—hematologic cancer	0.000128	0.000164	CcSEcCtD
Zanamivir—Skin disorder—Doxorubicin—hematologic cancer	0.000126	0.000162	CcSEcCtD
Zanamivir—Dyspnoea—Epirubicin—hematologic cancer	0.000125	0.000161	CcSEcCtD
Zanamivir—NEU2—Metabolism—EP300—hematologic cancer	0.000124	0.000556	CbGpPWpGaD
Zanamivir—Anorexia—Doxorubicin—hematologic cancer	0.000124	0.000159	CcSEcCtD
Zanamivir—Feeling abnormal—Methotrexate—hematologic cancer	0.000123	0.000159	CcSEcCtD
Zanamivir—Diarrhoea—Prednisone—hematologic cancer	0.000123	0.000158	CcSEcCtD
Zanamivir—Gastrointestinal pain—Methotrexate—hematologic cancer	0.000122	0.000158	CcSEcCtD
Zanamivir—Nausea—Dexamethasone—hematologic cancer	0.000122	0.000157	CcSEcCtD
Zanamivir—Nausea—Betamethasone—hematologic cancer	0.000122	0.000157	CcSEcCtD
Zanamivir—Decreased appetite—Epirubicin—hematologic cancer	0.000122	0.000157	CcSEcCtD
Zanamivir—Fatigue—Epirubicin—hematologic cancer	0.000121	0.000156	CcSEcCtD
Zanamivir—Pain—Epirubicin—hematologic cancer	0.00012	0.000154	CcSEcCtD
Zanamivir—Urticaria—Methotrexate—hematologic cancer	0.000119	0.000153	CcSEcCtD
Zanamivir—Dizziness—Prednisone—hematologic cancer	0.000118	0.000153	CcSEcCtD
Zanamivir—Body temperature increased—Methotrexate—hematologic cancer	0.000118	0.000152	CcSEcCtD
Zanamivir—Abdominal pain—Methotrexate—hematologic cancer	0.000118	0.000152	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	0.000118	0.000152	CcSEcCtD
Zanamivir—Dyspnoea—Doxorubicin—hematologic cancer	0.000116	0.000149	CcSEcCtD
Zanamivir—Feeling abnormal—Epirubicin—hematologic cancer	0.000115	0.000149	CcSEcCtD
Zanamivir—Gastrointestinal pain—Epirubicin—hematologic cancer	0.000115	0.000148	CcSEcCtD
Zanamivir—Vomiting—Prednisone—hematologic cancer	0.000114	0.000147	CcSEcCtD
Zanamivir—Rash—Prednisone—hematologic cancer	0.000113	0.000145	CcSEcCtD
Zanamivir—Dermatitis—Prednisone—hematologic cancer	0.000113	0.000145	CcSEcCtD
Zanamivir—Decreased appetite—Doxorubicin—hematologic cancer	0.000113	0.000145	CcSEcCtD
Zanamivir—Headache—Prednisone—hematologic cancer	0.000112	0.000145	CcSEcCtD
Zanamivir—Fatigue—Doxorubicin—hematologic cancer	0.000112	0.000144	CcSEcCtD
Zanamivir—Urticaria—Epirubicin—hematologic cancer	0.000111	0.000143	CcSEcCtD
Zanamivir—Pain—Doxorubicin—hematologic cancer	0.000111	0.000143	CcSEcCtD
Zanamivir—Abdominal pain—Epirubicin—hematologic cancer	0.000111	0.000143	CcSEcCtD
Zanamivir—Body temperature increased—Epirubicin—hematologic cancer	0.000111	0.000143	CcSEcCtD
Zanamivir—Hypersensitivity—Methotrexate—hematologic cancer	0.00011	0.000142	CcSEcCtD
Zanamivir—Asthenia—Methotrexate—hematologic cancer	0.000107	0.000138	CcSEcCtD
Zanamivir—Feeling abnormal—Doxorubicin—hematologic cancer	0.000107	0.000138	CcSEcCtD
Zanamivir—Nausea—Prednisone—hematologic cancer	0.000106	0.000137	CcSEcCtD
Zanamivir—Gastrointestinal pain—Doxorubicin—hematologic cancer	0.000106	0.000137	CcSEcCtD
Zanamivir—Hypersensitivity—Epirubicin—hematologic cancer	0.000103	0.000133	CcSEcCtD
Zanamivir—Urticaria—Doxorubicin—hematologic cancer	0.000103	0.000133	CcSEcCtD
Zanamivir—Abdominal pain—Doxorubicin—hematologic cancer	0.000102	0.000132	CcSEcCtD
Zanamivir—Body temperature increased—Doxorubicin—hematologic cancer	0.000102	0.000132	CcSEcCtD
Zanamivir—Diarrhoea—Methotrexate—hematologic cancer	0.000102	0.000132	CcSEcCtD
Zanamivir—Asthenia—Epirubicin—hematologic cancer	0.000101	0.000129	CcSEcCtD
Zanamivir—Dizziness—Methotrexate—hematologic cancer	9.9e-05	0.000128	CcSEcCtD
Zanamivir—Diarrhoea—Epirubicin—hematologic cancer	9.59e-05	0.000123	CcSEcCtD
Zanamivir—Hypersensitivity—Doxorubicin—hematologic cancer	9.55e-05	0.000123	CcSEcCtD
Zanamivir—Vomiting—Methotrexate—hematologic cancer	9.52e-05	0.000123	CcSEcCtD
Zanamivir—Rash—Methotrexate—hematologic cancer	9.44e-05	0.000122	CcSEcCtD
Zanamivir—Dermatitis—Methotrexate—hematologic cancer	9.43e-05	0.000121	CcSEcCtD
Zanamivir—Headache—Methotrexate—hematologic cancer	9.38e-05	0.000121	CcSEcCtD
Zanamivir—Asthenia—Doxorubicin—hematologic cancer	9.3e-05	0.00012	CcSEcCtD
Zanamivir—Dizziness—Epirubicin—hematologic cancer	9.27e-05	0.000119	CcSEcCtD
Zanamivir—NEU2—Metabolism—PIK3CA—hematologic cancer	9.19e-05	0.000411	CbGpPWpGaD
Zanamivir—Vomiting—Epirubicin—hematologic cancer	8.91e-05	0.000115	CcSEcCtD
Zanamivir—Nausea—Methotrexate—hematologic cancer	8.89e-05	0.000115	CcSEcCtD
Zanamivir—Diarrhoea—Doxorubicin—hematologic cancer	8.87e-05	0.000114	CcSEcCtD
Zanamivir—Rash—Epirubicin—hematologic cancer	8.84e-05	0.000114	CcSEcCtD
Zanamivir—Dermatitis—Epirubicin—hematologic cancer	8.83e-05	0.000114	CcSEcCtD
Zanamivir—Headache—Epirubicin—hematologic cancer	8.78e-05	0.000113	CcSEcCtD
Zanamivir—Dizziness—Doxorubicin—hematologic cancer	8.57e-05	0.00011	CcSEcCtD
Zanamivir—Nausea—Epirubicin—hematologic cancer	8.32e-05	0.000107	CcSEcCtD
Zanamivir—Vomiting—Doxorubicin—hematologic cancer	8.24e-05	0.000106	CcSEcCtD
Zanamivir—Rash—Doxorubicin—hematologic cancer	8.18e-05	0.000105	CcSEcCtD
Zanamivir—Dermatitis—Doxorubicin—hematologic cancer	8.17e-05	0.000105	CcSEcCtD
Zanamivir—Headache—Doxorubicin—hematologic cancer	8.12e-05	0.000105	CcSEcCtD
Zanamivir—Nausea—Doxorubicin—hematologic cancer	7.7e-05	9.92e-05	CcSEcCtD
Zanamivir—NEU2—Metabolism—AKT1—hematologic cancer	7.51e-05	0.000336	CbGpPWpGaD
